"My second poster at the AAN today. This shows that compared to interferon-beta, alemtuzumab treatment more than doubles your chances o...
"My second poster at the AAN today. This shows that compared to interferon-beta, alemtuzumab treatment more than doubles your chances o...
#MSBlog : Is it unrealistic to expect an improvement in your condition with early aggressive treatment? Epub : Graves et al. Alemtuzumab im...
#MSBlog : Alemtuzumab increases your chances of sustained or confirmed disability improvement compared to interferon-beta. "Apologies f...
Company restores access to multiple sclerosis drug after pressure from neurologists BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f703 (P...
Epub : Cossburn et al. Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis. Neurolog...
#MSBlog : How much is too expensive? The monoclonal antibody revolution! Allen Shaughnessy. Monoclonal antibodies: magic bullets with a heft...
Epub : Coles AJ. Alemtuzumab Therapy for Multiple Sclerosis . Neurotherapeutics . 2012 Nov 27. Alemtuzumab is a humanized monoclonal anti...